高级检索
当前位置: 首页 > 详情页

Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Institute of Clinical Medical Sciences, China–Japan Friendship Hospital, Beijing, China [2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China [3]National Clinical Research Center for Respiratory Diseases, Beijing, China [4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China, [5]Department of Medical Records, China–Japan Friendship Hospital, Beijing, China [6]Department of Medical Administration, China–Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: prediction model development validation in-hospital mortality acute exacerbation of COPD

摘要:
Background: In patients with chronic obstructive pulmonary disease (COPD), acute exacerbations affect patients' health and can lead to death. This study was aimed to develop a prediction model for in-hospital mortality in patients with acute exacerbations of COPD (AECOPD). Method: A retrospective study was performed in patients hospitalized for AECOPD between 2015 and 2019. Patients admitted between 2015 and 2017 were included to develop model and individuals admitted in the following 2 years were included for external validation. We analyzed variables that were readily available in clinical practice. Given that death was a rare outcome in this study, we fitted Firth penalized logistic regression. C statistic and calibration plot quantified the model performance. Optimism-corrected C statistic and slope were estimated by bootstrapping. Accordingly, the prediction model was adjusted and then transformed into risk score. Result: Between 2015 and 2017, 1,096 eligible patients were analyzed, with a mean age of 73 years and 67.8% male. The in-hospital mortality was 2.6%. Compared to survivors, non-survivors were older, more admitted from emergency, more frequently concomitant with respiratory failure, pneumothorax, hypoxic-hypercarbic encephalopathy, and had longer length of stay (LOS). Four variables were included into the final model: age, respiratory failure, pneumothorax, and LOS. In internal validation, C statistic was 0.9147, and the calibration slope was 1.0254. Their optimism-corrected values were 0.90887 and 0.9282, respectively, indicating satisfactory discrimination and calibration. When externally validated in 700 AECOPD patients during 2018 and 2019, the model demonstrated good discrimination with a C statistic of 0.8176. Calibration plot illustrated a varying discordance between predicted and observed mortality. It demonstrated good calibration in low-risk patients with predicted mortality rate <= 10% (P = 0.3253) but overestimated mortality in patients with predicted rate >10% (P < 0.0001). The risk score of 20 was regarded as a threshold with an optimal Youden index of 0.7154. Conclusion: A simple prediction model for AECOPD in-hospital mortality has been developed and externally validated. Based on available data in clinical setting, the model could serve as an easily used instrument for clinical decision-making. Complications emerged as strong predictors, underscoring an important role of disease management in improving patients' prognoses during exacerbation episodes.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
JCR分区:
出版当年[2019]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Institute of Clinical Medical Sciences, China–Japan Friendship Hospital, Beijing, China [2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China [3]National Clinical Research Center for Respiratory Diseases, Beijing, China [4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China,
通讯作者:
通讯机构: [2]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China [3]National Clinical Research Center for Respiratory Diseases, Beijing, China [4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China,
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)